✉  info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Nuclear Medicine Market Research Report By Application (Diagnostic Imaging, Therapeutic Applications, Radiopharmaceutical Production, Research Applications), By Radioisotope Type (Technetium-99m, Iodine-131, Fluorine-18, Yttrium-90), By End User (Hospitals, Diagnostic Imaging Centers, Academic Research Institutions, Pharmaceutical Companies), By Procedure (Positron Emission Tomography, Single-Photon Emission Computed Tomography, Radiotherapy, Brachytherapy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and


ID: MRFR/Pharma/5211-CR | 200 Pages | Author: Rahul Gotadki| April 2025

Nuclear Medicine Market Segmentation




  • Nuclear Medicine Market By Application (USD Billion, 2019-2035)




    • Diagnostic Imaging




    • Therapeutic Applications




    • Radiopharmaceutical Production




    • Research Applications








  • Nuclear Medicine Market By Radioisotope Type (USD Billion, 2019-2035)




    • Technetium-99m




    • Iodine-131




    • Fluorine-18




    • Yttrium-90








  • Nuclear Medicine Market By End User (USD Billion, 2019-2035)




    • Hospitals




    • Diagnostic Imaging Centers




    • Academic Research Institutions




    • Pharmaceutical Companies








  • Nuclear Medicine Market By Procedure (USD Billion, 2019-2035)




    • Positron Emission Tomography




    • Single-Photon Emission Computed Tomography




    • Radiotherapy




    • Brachytherapy








  • Nuclear Medicine Market By Regional (USD Billion, 2019-2035)




    • North America




    • Europe




    • South America




    • Asia Pacific




    • Middle East and Africa






Nuclear Medicine Market Regional Outlook (USD Billion, 2019-2035)




  • North America Outlook (USD Billion, 2019-2035)




    • North America Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • North America Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • North America Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • North America Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • North America Nuclear Medicine Market by Regional Type




      • US




      • Canada






    • US Outlook (USD Billion, 2019-2035)




    • US Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • US Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • US Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • US Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • CANADA Outlook (USD Billion, 2019-2035)




    • CANADA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • CANADA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • CANADA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • CANADA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy








  • Europe Outlook (USD Billion, 2019-2035)




    • Europe Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • Europe Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • Europe Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • Europe Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • Europe Nuclear Medicine Market by Regional Type




      • Germany




      • UK




      • France




      • Russia




      • Italy




      • Spain




      • Rest of Europe






    • GERMANY Outlook (USD Billion, 2019-2035)




    • GERMANY Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • GERMANY Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • GERMANY Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • GERMANY Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • UK Outlook (USD Billion, 2019-2035)




    • UK Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • UK Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • UK Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • UK Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • FRANCE Outlook (USD Billion, 2019-2035)




    • FRANCE Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • FRANCE Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • FRANCE Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • FRANCE Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • RUSSIA Outlook (USD Billion, 2019-2035)




    • RUSSIA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • RUSSIA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • RUSSIA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • RUSSIA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • ITALY Outlook (USD Billion, 2019-2035)




    • ITALY Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • ITALY Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • ITALY Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • ITALY Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • SPAIN Outlook (USD Billion, 2019-2035)




    • SPAIN Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • SPAIN Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • SPAIN Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • SPAIN Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • REST OF EUROPE Outlook (USD Billion, 2019-2035)




    • REST OF EUROPE Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • REST OF EUROPE Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • REST OF EUROPE Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • REST OF EUROPE Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy








  • APAC Outlook (USD Billion, 2019-2035)




    • APAC Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • APAC Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • APAC Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • APAC Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • APAC Nuclear Medicine Market by Regional Type




      • China




      • India




      • Japan




      • South Korea




      • Malaysia




      • Thailand




      • Indonesia




      • Rest of APAC






    • CHINA Outlook (USD Billion, 2019-2035)




    • CHINA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • CHINA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • CHINA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • CHINA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • INDIA Outlook (USD Billion, 2019-2035)




    • INDIA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • INDIA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • INDIA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • INDIA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • JAPAN Outlook (USD Billion, 2019-2035)




    • JAPAN Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • JAPAN Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • JAPAN Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • JAPAN Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • SOUTH KOREA Outlook (USD Billion, 2019-2035)




    • SOUTH KOREA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • SOUTH KOREA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • SOUTH KOREA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • SOUTH KOREA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • MALAYSIA Outlook (USD Billion, 2019-2035)




    • MALAYSIA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • MALAYSIA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • MALAYSIA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • MALAYSIA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • THAILAND Outlook (USD Billion, 2019-2035)




    • THAILAND Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • THAILAND Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • THAILAND Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • THAILAND Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • INDONESIA Outlook (USD Billion, 2019-2035)




    • INDONESIA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • INDONESIA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • INDONESIA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • INDONESIA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • REST OF APAC Outlook (USD Billion, 2019-2035)




    • REST OF APAC Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • REST OF APAC Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • REST OF APAC Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • REST OF APAC Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy








  • South America Outlook (USD Billion, 2019-2035)




    • South America Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • South America Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • South America Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • South America Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • South America Nuclear Medicine Market by Regional Type




      • Brazil




      • Mexico




      • Argentina




      • Rest of South America






    • BRAZIL Outlook (USD Billion, 2019-2035)




    • BRAZIL Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • BRAZIL Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • BRAZIL Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • BRAZIL Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • MEXICO Outlook (USD Billion, 2019-2035)




    • MEXICO Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • MEXICO Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • MEXICO Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • MEXICO Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • ARGENTINA Outlook (USD Billion, 2019-2035)




    • ARGENTINA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • ARGENTINA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • ARGENTINA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • ARGENTINA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)




    • REST OF SOUTH AMERICA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • REST OF SOUTH AMERICA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • REST OF SOUTH AMERICA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • REST OF SOUTH AMERICA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy








  • MEA Outlook (USD Billion, 2019-2035)




    • MEA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • MEA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • MEA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • MEA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • MEA Nuclear Medicine Market by Regional Type




      • GCC Countries




      • South Africa




      • Rest of MEA






    • GCC COUNTRIES Outlook (USD Billion, 2019-2035)




    • GCC COUNTRIES Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • GCC COUNTRIES Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • GCC COUNTRIES Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • GCC COUNTRIES Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • SOUTH AFRICA Outlook (USD Billion, 2019-2035)




    • SOUTH AFRICA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • SOUTH AFRICA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • SOUTH AFRICA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • SOUTH AFRICA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy






    • REST OF MEA Outlook (USD Billion, 2019-2035)




    • REST OF MEA Nuclear Medicine Market by Application Type




      • Diagnostic Imaging




      • Therapeutic Applications




      • Radiopharmaceutical Production




      • Research Applications






    • REST OF MEA Nuclear Medicine Market by Radioisotope Type




      • Technetium-99m




      • Iodine-131




      • Fluorine-18




      • Yttrium-90






    • REST OF MEA Nuclear Medicine Market by End User Type




      • Hospitals




      • Diagnostic Imaging Centers




      • Academic Research Institutions




      • Pharmaceutical Companies






    • REST OF MEA Nuclear Medicine Market by Procedure Type




      • Positron Emission Tomography




      • Single-Photon Emission Computed Tomography




      • Radiotherapy




      • Brachytherapy








 


 

Research Methodology on the Nuclear Medicine Market 


Introduction:

This research report focuses on the Global Nuclear Medicine Market. The primary objective of this research report is to provide valuable insights and effective strategies to industry stakeholders to help them make well-informed decisions. This report analyses the size of the Global Nuclear Medicine Market and provides growth forecasts over the assessment period. The latest trends and opportunities are also reviewed in the report to identify promising areas of market growth.


The research methodology adopted includes both primary and secondary research. Primary research includes interviews with industry stakeholders such as nuclear medicine manufacturing companies, industry experts and other stakeholders. The findings of the primary research are supplemented using secondary research methods, such as printed and digital databases, national and international reports and official government documents. The analysis is performed using both qualitative and quantitative tools.


Objectives of the Study:

The primary objective of the study is to calculate the size of the Global Nuclear Medicine Market. The secondary objectives of the study include:


Identification of potential growth opportunities in the Global Nuclear Medicine Market


Analyzing the driving factors and challenges affecting the market growth


Evaluation of industry trends


Categorization of factors impacting market growth


Estimation of the competitive landscape of the Global Nuclear Medicine Market


Identification of the key players operating in the Global Nuclear Medicine Market


Research Design:

The scope of this research report is limited to the assessment of the Global Nuclear Medicine Market. The research design used for this report is a combination of both primary and secondary research.



  •  Primary Research:


The primary research conducted as part of this report includes interviews with industry stakeholders such as nuclear medicine manufacturing companies, industry experts, and other stakeholders. The primary research also includes surveys of healthcare institutions and providers.



  •  Secondary Research:


The secondary research includes data gathered from printed and digital databases, national and international reports, and official government documents.


Choice of Data Sources:

The data sources used for this report include both primary and secondary research. Primary data sources include interviews with industry stakeholders such as nuclear medicine manufacturing companies, industry experts and other stakeholders. The secondary research data sources include printed and digital databases, national and international reports, and official government documents.


Research Methodology:

The research methodology adopted for this report includes both primary and secondary research. The primary research includes interviews with industry stakeholders such as nuclear medicine manufacturing companies, industry experts, and other stakeholders. The secondary research includes printed and digital databases, national and international reports, and official government documents. Both qualitative and quantitative tools are used to analyse the data collected from both primary and secondary sources.


Base of Data Projection:

The base of data projection used in this report is the historical data gathered from both primary and secondary research.


Forecasting Methodology Adopted:

The forecasting methodology adopted for this report takes into account multiple macros and microeconomic factors including market trends and drivers, market dynamics, and industry analysis.


Objectivity of Findings:

The objective of the findings presented in this report is to provide valuable insights and effective strategies to industry stakeholders to help them make well-informed decisions.


Assumptions:

It is assumed that the Global Nuclear Medicine Market will continue to witness an increase in demand in the forecast period, driven by technological advancements and increasing awareness about the benefits of nuclear medicine.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents


 




  1. EXECUTIVE SUMMARY




    1. Market Overview




    2. Key Findings




    3. Market Segmentation




    4. Competitive Landscape




    5. Challenges and Opportunities




    6. Future Outlook






 


 




  1. MARKET INTRODUCTION




    1. Definition




    2. Scope of the study




      1. Research Objective




      2. Assumption




      3. Limitations








  2. RESEARCH METHODOLOGY




    1. Overview




    2. Data Mining




    3. Secondary Research




    4. Primary Research




      1. Primary Interviews and Information Gathering Process




      2. Breakdown of Primary Respondents






    5. Forecasting Model




    6. Market Size Estimation




      1. Bottom-Up Approach




      2. Top-Down Approach






    7. Data Triangulation




    8. Validation






 


 




  1. MARKET DYNAMICS




    1. Overview




    2. Drivers




    3. Restraints




    4. Opportunities






  2. MARKET FACTOR ANALYSIS




    1. Value chain Analysis




    2. Porter's Five Forces Analysis




      1. Bargaining Power of Suppliers




      2. Bargaining Power of Buyers




      3. Threat of New Entrants




      4. Threat of Substitutes




      5. Intensity of Rivalry






    3. COVID-19 Impact Analysis




      1. Market Impact Analysis




      2. Regional Impact




      3. Opportunity and Threat Analysis








 


 




  1. Nuclear Medicine Market, BY Application (USD Billion)




    1. Diagnostic Imaging




    2. Therapeutic Applications




    3. Radiopharmaceutical Production




    4. Research Applications






  2. Nuclear Medicine Market, BY Radioisotope Type (USD Billion)




    1. Technetium-99m




    2. Iodine-131




    3. Fluorine-18




    4. Yttrium-90






  3. Nuclear Medicine Market, BY End User (USD Billion)




    1. Hospitals




    2. Diagnostic Imaging Centers




    3. Academic Research Institutions




    4. Pharmaceutical Companies






  4. Nuclear Medicine Market, BY Procedure (USD Billion)




    1. Positron Emission Tomography




    2. Single-Photon Emission Computed Tomography




    3. Radiotherapy




    4. Brachytherapy






  5. Nuclear Medicine Market, BY Regional (USD Billion)




    1. North America




      1. US




      2. Canada






    2. Europe




      1. Germany




      2. UK




      3. France




      4. Russia




      5. Italy




      6. Spain




      7. Rest of Europe






    3. APAC




      1. China




      2. India




      3. Japan




      4. South Korea




      5. Malaysia




      6. Thailand




      7. Indonesia




      8. Rest of APAC






    4. South America




      1. Brazil




      2. Mexico




      3. Argentina




      4. Rest of South America






    5. MEA




      1. GCC Countries




      2. South Africa




      3. Rest of MEA








 


 




  1. Competitive Landscape




    1. Overview




    2. Competitive Analysis




    3. Market share Analysis




    4. Major Growth Strategy in the Nuclear Medicine Market




    5. Competitive Benchmarking




    6. Leading Players in Terms of Number of Developments in the Nuclear Medicine Market




    7. Key developments and growth strategies




      1. New Product Launch/Service Deployment




      2. Merger & Acquisitions




      3. Joint Ventures






    8. Major Players Financial Matrix




      1. Sales and Operating Income




      2. Major Players R&D Expenditure. 2023








  2. Company Profiles




    1. MediRadiant




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    2. Bracco Imaging




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    3. Nordion




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    4. TheraBiologics




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    5. United Imaging Healthcare




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    6. Philips




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    7. Canon Medical Systems




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    8. SelenoMed




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    9. Radiopharm Theranostics




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    10. AquaBounty Technologies




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    11. Lantheus Medical Imaging




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    12. Bayer




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    13. Elekta




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    14. Siemens




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    15. General Electric




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies








  3. Appendix




    1. References




    2. Related Reports






LIST Of tables


 




  1. LIST OF ASSUMPTIONS




  2. North America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  3. North America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  4. North America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  5. North America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  6. North America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  7. US Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  8. US Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  9. US Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  10. US Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  11. US Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  12. Canada Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  13. Canada Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  14. Canada Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  15. Canada Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  16. Canada Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  17. Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  18. Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  19. Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  20. Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  21. Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  22. Germany Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  23. Germany Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  24. Germany Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  25. Germany Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  26. Germany Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  27. UK Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  28. UK Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  29. UK Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  30. UK Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  31. UK Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  32. France Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  33. France Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  34. France Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  35. France Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  36. France Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  37. Russia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  38. Russia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  39. Russia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  40. Russia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  41. Russia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  42. Italy Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  43. Italy Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  44. Italy Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  45. Italy Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  46. Italy Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  47. Spain Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  48. Spain Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  49. Spain Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  50. Spain Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  51. Spain Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  52. Rest of Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  53. Rest of Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  54. Rest of Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  55. Rest of Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  56. Rest of Europe Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  57. APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  58. APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  59. APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  60. APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  61. APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  62. China Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  63. China Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  64. China Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  65. China Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  66. China Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  67. India Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  68. India Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  69. India Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  70. India Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  71. India Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  72. Japan Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  73. Japan Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  74. Japan Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  75. Japan Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  76. Japan Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  77. South Korea Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  78. South Korea Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  79. South Korea Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  80. South Korea Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  81. South Korea Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  82. Malaysia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  83. Malaysia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  84. Malaysia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  85. Malaysia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  86. Malaysia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  87. Thailand Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  88. Thailand Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  89. Thailand Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  90. Thailand Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  91. Thailand Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  92. Indonesia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  93. Indonesia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  94. Indonesia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  95. Indonesia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  96. Indonesia Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  97. Rest of APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  98. Rest of APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  99. Rest of APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  100. Rest of APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  101. Rest of APAC Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  102. South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  103. South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  104. South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  105. South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  106. South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  107. Brazil Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  108. Brazil Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  109. Brazil Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  110. Brazil Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  111. Brazil Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  112. Mexico Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  113. Mexico Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  114. Mexico Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  115. Mexico Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  116. Mexico Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  117. Argentina Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  118. Argentina Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  119. Argentina Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  120. Argentina Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  121. Argentina Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  122. Rest of South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  123. Rest of South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  124. Rest of South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  125. Rest of South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  126. Rest of South America Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  127. MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  128. MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  129. MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  130. MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  131. MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  132. GCC Countries Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  133. GCC Countries Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  134. GCC Countries Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  135. GCC Countries Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  136. GCC Countries Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  137. South Africa Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  138. South Africa Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  139. South Africa Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  140. South Africa Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  141. South Africa Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  142. Rest of MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  143. Rest of MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE TYPE, 2019-2035 (USD Billions)




  144. Rest of MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)




  145. Rest of MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY PROCEDURE, 2019-2035 (USD Billions)




  146. Rest of MEA Nuclear Medicine Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL




  148. ACQUISITION/PARTNERSHIP




 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


LIST Of figures


 




  1. MARKET SYNOPSIS




  2. NORTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS




  3. US NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  4. US NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  5. US NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  6. US NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  7. US NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  8. CANADA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  9. CANADA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  10. CANADA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  11. CANADA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  12. CANADA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  13. EUROPE NUCLEAR MEDICINE MARKET ANALYSIS




  14. GERMANY NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  15. GERMANY NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  16. GERMANY NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  17. GERMANY NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  18. GERMANY NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  19. UK NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  20. UK NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  21. UK NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  22. UK NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  23. UK NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  24. FRANCE NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  25. FRANCE NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  26. FRANCE NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  27. FRANCE NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  28. FRANCE NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  29. RUSSIA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  30. RUSSIA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  31. RUSSIA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  32. RUSSIA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  33. RUSSIA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  34. ITALY NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  35. ITALY NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  36. ITALY NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  37. ITALY NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  38. ITALY NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  39. SPAIN NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  40. SPAIN NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  41. SPAIN NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  42. SPAIN NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  43. SPAIN NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  44. REST OF EUROPE NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  45. REST OF EUROPE NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  46. REST OF EUROPE NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  47. REST OF EUROPE NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  48. REST OF EUROPE NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  49. APAC NUCLEAR MEDICINE MARKET ANALYSIS




  50. CHINA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  51. CHINA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  52. CHINA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  53. CHINA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  54. CHINA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  55. INDIA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  56. INDIA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  57. INDIA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  58. INDIA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  59. INDIA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  60. JAPAN NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  61. JAPAN NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  62. JAPAN NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  63. JAPAN NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  64. JAPAN NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  65. SOUTH KOREA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  66. SOUTH KOREA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  67. SOUTH KOREA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  68. SOUTH KOREA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  69. SOUTH KOREA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  70. MALAYSIA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  71. MALAYSIA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  72. MALAYSIA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  73. MALAYSIA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  74. MALAYSIA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  75. THAILAND NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  76. THAILAND NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  77. THAILAND NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  78. THAILAND NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  79. THAILAND NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  80. INDONESIA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  81. INDONESIA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  82. INDONESIA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  83. INDONESIA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  84. INDONESIA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  85. REST OF APAC NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  86. REST OF APAC NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  87. REST OF APAC NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  88. REST OF APAC NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  89. REST OF APAC NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  90. SOUTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS




  91. BRAZIL NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  92. BRAZIL NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  93. BRAZIL NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  94. BRAZIL NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  95. BRAZIL NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  96. MEXICO NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  97. MEXICO NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  98. MEXICO NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  99. MEXICO NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  100. MEXICO NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  101. ARGENTINA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  102. ARGENTINA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  103. ARGENTINA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  104. ARGENTINA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  105. ARGENTINA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  106. REST OF SOUTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  107. REST OF SOUTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  108. REST OF SOUTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  109. REST OF SOUTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  110. REST OF SOUTH AMERICA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  111. MEA NUCLEAR MEDICINE MARKET ANALYSIS




  112. GCC COUNTRIES NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  113. GCC COUNTRIES NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  114. GCC COUNTRIES NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  115. GCC COUNTRIES NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  116. GCC COUNTRIES NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  117. SOUTH AFRICA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  118. SOUTH AFRICA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  119. SOUTH AFRICA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  120. SOUTH AFRICA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  121. SOUTH AFRICA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  122. REST OF MEA NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION




  123. REST OF MEA NUCLEAR MEDICINE MARKET ANALYSIS BY RADIOISOTOPE TYPE




  124. REST OF MEA NUCLEAR MEDICINE MARKET ANALYSIS BY END USER




  125. REST OF MEA NUCLEAR MEDICINE MARKET ANALYSIS BY PROCEDURE




  126. REST OF MEA NUCLEAR MEDICINE MARKET ANALYSIS BY REGIONAL




  127. KEY BUYING CRITERIA OF NUCLEAR MEDICINE MARKET




  128. RESEARCH PROCESS OF MRFR




  129. DRO ANALYSIS OF NUCLEAR MEDICINE MARKET




  130. DRIVERS IMPACT ANALYSIS: NUCLEAR MEDICINE MARKET




  131. RESTRAINTS IMPACT ANALYSIS: NUCLEAR MEDICINE MARKET




  132. SUPPLY / VALUE CHAIN: NUCLEAR MEDICINE MARKET




  133. NUCLEAR MEDICINE MARKET, BY APPLICATION, 2025 (% SHARE)




  134. NUCLEAR MEDICINE MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)




  135. NUCLEAR MEDICINE MARKET, BY RADIOISOTOPE TYPE, 2025 (% SHARE)




  136. NUCLEAR MEDICINE MARKET, BY RADIOISOTOPE TYPE, 2019 TO 2035 (USD Billions)




  137. NUCLEAR MEDICINE MARKET, BY END USER, 2025 (% SHARE)




  138. NUCLEAR MEDICINE MARKET, BY END USER, 2019 TO 2035 (USD Billions)




  139. NUCLEAR MEDICINE MARKET, BY PROCEDURE, 2025 (% SHARE)




  140. NUCLEAR MEDICINE MARKET, BY PROCEDURE, 2019 TO 2035 (USD Billions)




  141. NUCLEAR MEDICINE MARKET, BY REGIONAL, 2025 (% SHARE)




  142. NUCLEAR MEDICINE MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)




  143. BENCHMARKING OF MAJOR COMPETITORS




 

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
report-img
Related Reports
report-img
Nuclear Medicine Equipment Market Research Report-Forecast till 2034
report-img
US Nuclear Medicine Market
report-img
Nuclear Medicine Radioisotopes Market Research Report - Forecast 2035
report-img
Nuclear Medicine Therapeutic Alpha Beta Emitters Brachytherapy Market Research Report - Forecast ...
Press Release
pr-img
Nuclear Medicine Market Valuation To Reach USD 27.96 billion by 2032
Logo
861332069 Dmca
Paypal new Ssl cf new
Services Syndicate Reports Category Intelligence News How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners Paymentoptions
ISO Certifications
Iso new
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)
📞  +91 2269738890(APAC)

© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)